11 results
Keyword paclitaxel Remove keyword
Categories
Human Remove Human filter
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Paediatric investigation plans Remove Paediatric investigation plans filter
Medicine type
Biosimilar Remove Biosimilar filter
-
List item
Human medicine European public assessment report (EPAR): Mvasi
bevacizumab, Carcinoma, Renal Cell, Peritoneal Neoplasms, Ovarian Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Fallopian Tube Neoplasms
Date of authorisation: 15/01/2018,
, 
, Revision: 9, Authorised, Last updated: 03/11/2020
medicines carboplatin and paclitaxel. The cancer responded to treatment … -
List item
Human medicine European public assessment report (EPAR): Equidacent
bevacizumab, Colorectal Neoplasms, Breast Neoplasms, Ovarian Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell
Date of authorisation: 24/09/2020,, , Revision: 1, Authorised, Last updated: 16/11/2020
with the cancer medicines paclitaxel and carboplatin. After around … -
List item
Human medicine European public assessment report (EPAR): Aybintio
bevacizumab, Colorectal Neoplasms, Breast Neoplasms, Ovarian Neoplasms, Fallopian Tube Neoplasms, Peritoneal Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms
Date of authorisation: 19/08/2020,, , Revision: 1, Authorised, Last updated: 09/12/2020
with the cancer medicines paclitaxel and carboplatin. The cancer … Aybintio in combination with paclitaxel is indicated for first-line … combination with carboplatin and paclitaxel is indicated for the front-line … -
List item
Human medicine European public assessment report (EPAR): Zirabev
bevacizumab, Colorectal Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms
Date of authorisation: 14/02/2019,, , Revision: 7, Authorised, Last updated: 07/01/2021
medicines carboplatin and paclitaxel. The cancer improved in 45 … rectum. Zirabev in combination with paclitaxel is indicated for first-line … combination with carboplatin and paclitaxel is indicated for the front-line … -
List item
Human medicine European public assessment report (EPAR): Zercepac (updated)
trastuzumab, Breast Neoplasms, Stomach Neoplasms
Date of authorisation: 27/07/2020,, , Revision: 2, Authorised, Last updated: 09/02/2021
with other cancer medicines: paclitaxel or docetaxel, or with another … in combination with paclitaxel for the treatment of those … cyclophosphamide, in combination with paclitaxel or docetaxel. - in combination … -
List item
Human medicine European public assessment report (EPAR): Trazimera
trastuzumab, Stomach Neoplasms, Breast Neoplasms
Date of authorisation: 26/07/2018,, , Revision: 6, Authorised, Last updated: 09/07/2020
other cancer medicines: with paclitaxel or docetaxel, or with another … other cancer medicines: with paclitaxel or docetaxel, or with another … -
List item
Human medicine European public assessment report (EPAR): Onbevzi
bevacizumab, Colorectal Neoplasms, Breast Neoplasms, Ovarian Neoplasms, Fallopian Tube Neoplasms, Peritoneal Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms
Date of authorisation: 11/01/2021,, , Authorised, Last updated: 05/03/2021
with the cancer medicines paclitaxel and carboplatin. The cancer … with the cancer medicines paclitaxel and carboplatin. The cancer … Onbevzi in combination with paclitaxel is indicated for first-line … -
List item
Human medicine European public assessment report (EPAR): Ogivri
trastuzumab, Stomach Neoplasms, Breast Neoplasms
Date of authorisation: 12/12/2018,, , Revision: 5, Authorised, Last updated: 29/01/2021
other cancer medicines: with paclitaxel or docetaxel, or with another … with other cancer medicines (paclitaxel or docetaxel). A response … in combination with paclitaxel for the treatment of those … -
List item
Human medicine European public assessment report (EPAR): Herzuma (updated)
trastuzumab, Stomach Neoplasms, Breast Neoplasms
Date of authorisation: 08/02/2018,, , Revision: 11, Authorised, Last updated: 01/03/2021
other cancer medicines: with paclitaxel or docetaxel, or with another … other cancer medicines: with paclitaxel or docetaxel, or with another … -
List item
Human medicine European public assessment report (EPAR): Kanjinti (updated)
trastuzumab, Stomach Neoplasms, Breast Neoplasms
Date of authorisation: 16/05/2018,, , Revision: 7, Authorised, Last updated: 22/02/2021
other cancer medicines: with paclitaxel or docetaxel, or with another … other cancer medicines: with paclitaxel or docetaxel, or with another … -
List item
Human medicine European public assessment report (EPAR): Ontruzant (updated)
trastuzumab, Stomach Neoplasms, Breast Neoplasms
Date of authorisation: 15/11/2017,, , Revision: 8, Authorised, Last updated: 10/02/2021
other cancer medicines: with paclitaxel or docetaxel, or with another … other cancer medicines: with paclitaxel or docetaxel, or with another …